Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1130.3000 10.40 (0.93%)
NSE Oct 10, 2025 15:31 PM
Volume: 1.5M
 

logo
Aurobindo Pharma Ltd.
13 Feb 2017
1130.30
0.93%
buy
Results Update: Aurobindo Pharma Ltd.
by HDFC Securities
HDFC Securities
Revenue increased by 3.52% to Rs. 3844.47 Cr in Q3FY17 when compared to the previous quarter. Also, it increased by 11.69% when compared with Q3FY16.
 
Aurobindo Pharma Ltd. has an average target of 1403.50 from 10 brokers.
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - October 10, 2025
The Baseline | 10 Oct 2025
Market closes higher, Capacit'e Infra bags Rs 542 cr order from IIT Bombay
Trendlyne Marketwatch | 10 Oct 2025
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020